Article
BCIU Appoints Three New Board Directors
The Business Council for International Understanding (BCIU) recently held its mid-year Board of Directors meeting and Members meeting where three new directors were appointed. The appointment of C.D. Glin, Global Head of Philanthropy, PepsiCo; Menassie Tadesse, President of Emerging Markets, Viatris; and Angela Wasunna, Vice President, Global Policy and Public Affairs Lead, Emerging Markets, Pfizer, was approved on July 22, 2022.
“I am thrilled to welcome C.D., Menassie, and Angela to the Board,” said BCIU Board Chair Jim Nevels. “Their range of global insights, sector expertise, and diverse backgrounds will help strengthen BCIU’s reputation as one of the world’s most impactful international institutions.”
These appointments support BCIU’s goals of recruiting directors who are based in key global hubs, align with the organization’s expanding thematic and vertical programming in the fields of agriculture, climate, and life sciences, among others, and broaden the board’s diversity in gender, background, and thought.
Glin is the Vice President of the PepsiCo Foundation and Global Head of Philanthropy at PepsiCo. In this role, Glin leads the social-and community-driven impact efforts for the philanthropic arm of the company and a portfolio of global employee engagement programs designed to harness the expertise and passion of PepsiCo’s more than 290,000 employees to create positive, enduring change in communities around the world.
Tadesse is currently President of Emerging Markets at Viatris, a new kind of healthcare company created by the merger of Mylan and Upjohn, a legacy division of Pfizer. In this role, he oversees 125 markets over 200 brands and leads a team of 3,500 people.
Wasunna is Vice President of Emerging Markets Global Policy and Public Affairs at Pfizer. In her role, she oversees government engagement in Emerging Markets (Latin America, Africa/Middle East and Emerging Asia) and works to advance policies to fulfil Pfizer’s purpose: To deliver breakthroughs that change patients’ lives.